Literature DB >> 3771192

Immunomodulation by tamoxifen and pergolide.

E Nagy, I Berczi.   

Abstract

Treatment of rats with tamoxifen citrate or pergolide mesylate was as effective in inhibiting antibody formation and contact sensitivity skin reactions as was hypophysectomy. The immunocompetence of tamoxifen citrate- and pergolide mesylate-suppressed animals could be fully restored by additional treatment with prolactin or growth hormone.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3771192     DOI： 10.1016/0162-3109(86)90040-8

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN： 0162-3109


  4 in total

Review 1.  The role of prolactin in the pathogenesis of autoimmune disease.

Authors:  Istvan Berczi
Journal:  Endocr Pathol       Date:  1993-12       Impact factor: 3.943

2.  Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen.

Authors:  J Lukac; Z Kusić; D Kordić; M Koncar; A Bolanca
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  "Iron-saturated" bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice.

Authors:  Xueying Sun; Ruohan Jiang; Aneta Przepiorski; Shiva Reddy; Kate P Palmano; Geoffrey W Krissansen
Journal:  BMC Cancer       Date:  2012-12-11       Impact factor: 4.430

4.  Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation.

Authors:  Gang Ma; Jianjun He; Yang Yu; Yixiang Xu; Xiaobin Yu; Jarrod Martinez; David M Lonard; Jianming Xu
Journal:  Int J Biol Sci       Date:  2015-04-11       Impact factor: 6.580
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.